24 HR Exxua 36.3 MG Extended Release Oral Tablet

RxCUI: 2672385
RxNorm name: 24 HR Exxua 36.3 MG Extended Release Oral Tablet
Display name: 24 HR Exxua 36.3 MG Extended Release Oral Tablet
Full name: 24 HR Exxua 36.3 MG Extended Release Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EXXUA	GEPIRONE	Aytu Therapeutics, LLC	0c78edd8-6acb-433c-9d34-2527da8d64e1	2026-07-14	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2672385

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
0c78edd8-6acb-433c-9d34-2527da8d64e1	EXXUA 36.3 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR gepirone 36.3 MG Extended Release Oral Tablet [Exxua] [SBD] · 24 HR Exxua 36.3 MG Extended Release Oral Tablet [SY] · Exxua 36.3 MG (equivalent to 40 MG gepirone hydrochloride) 24 HR Extended Release Oral Tablet [SY]	4	2	These highlights do not include all the information needed to use EXXUA ™ safely and effectively. See full prescribing information for EXXUA . EXXUA ( gepirone ) extended-release tablets for oral use Initial U.S. Approval: 2023	20251016